Anticonvulsant activity of antiparkinsonism agents.
D000818:Animals; D000927:Anticonvulsants / Q000494:pharmacology*; D002648:Child; D002675:Child, Preschool; D004597:Electroshock; D005260:Female; D005901:Glaucoma; D006801:Humans; D007223:Infant; D008297:Male; D051379:Mice; D009207:Myoclonus / Q000188:drug therapy*; D009422:Nervous System Diseases / Q000139:chemically induced; D010276:Parasympatholytics / Q000494:pharmacology* / Q000633:toxicity; D010433:Pentylenetetrazole; D011352:Procyclidine / Q000494:pharmacology / Q000633:toxicity; D011759:Pyrrolidines / Q000494:pharmacology*; D012640:Seizures / Q000188:drug therapy*; D014282:Trihexyphenidyl / Q000494:pharmacology*; D014525:Urethral Stricture
D000927:Anticonvulsants; D010276:Parasympatholytics; D011759:Pyrrolidines; D014282:Trihexyphenidyl; D011352:Procyclidine; D010433:Pentylenetetrazole